Pearce E J, Hall B F, Sher A
Immunology and Cell Biology Section, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
J Immunol. 1990 Apr 1;144(7):2751-6.
Schistosoma mansoni parasites recovered from the blood stream were found to be nonactivators of the alternative complement pathway (ACP) when exposed to sera of homologous but not heterologous host species. Schistosomes could be converted into activators of the homologous ACP by treatment with phospholipase C. Antibodies to either human or guinea pig decay accelerating factor (DAF), a 70-kDa glycosylphosphatidylinositol anchored membrane glycoprotein which controls ACP activation on the mammalian cell plasma membrane, bound to the surface of immature schistosomes and immunoprecipitated a molecule of similar molecular mass from detergent extracts of surface iodinated parasites. Phospholipase C treatment drastically reduced the reactivity of the worms with the anti-DAF antibodies. These data suggest that schistosomes evade the ACP by inserting functional host DAF into their surfaces, possibly through adsorption of the molecule's lipophilic diacyglycerol membrane anchor moiety into the outer lipid bilayer of the parasite.
从血流中回收的曼氏血吸虫寄生虫在暴露于同源而非异源宿主物种的血清时,被发现是非替代补体途径(ACP)的激活剂。通过用磷脂酶C处理,血吸虫可转化为同源ACP的激活剂。针对人或豚鼠衰变加速因子(DAF)的抗体,一种控制哺乳动物细胞质膜上ACP激活的70 kDa糖基磷脂酰肌醇锚定膜糖蛋白,与未成熟血吸虫的表面结合,并从表面碘化寄生虫的去污剂提取物中免疫沉淀出一个分子量相似的分子。磷脂酶C处理大大降低了蠕虫与抗DAF抗体的反应性。这些数据表明,血吸虫可能通过将功能性宿主DAF插入其表面来逃避ACP,这可能是通过将该分子的亲脂性二酰甘油膜锚定部分吸附到寄生虫的外脂质双层中实现的。